Have multiple conditions? Click here

New Clinical Trials for COPD

There are currently many chronic obstructive pulmonary disease clinical trials being conducted. Some focus on testing new medications while others look at better diagnosis, management and prevention methods. Others focus on preventing and treating flare-ups that are specific incidences where symptoms intensify. Chronic obstructive pulmonary disease clinical research sometimes studies ways to slow or even reverse progress of the disease. If you have been diagnosed with chronic obstructive pulmonary disease and are interested in taking part in a clinical trial, please review the list of current trials being conducted.
 

What is COPD?

Chronic obstructive pulmonary disease (COPD) is chronic bronchitis combined with emphysema. It is a condition that causes the airways in the lungs to narrow. The main symptom is shortness of breath and the main cause is smoking. Chronic obstructive pulmonary disease is a difficult condition to reverse and the symptoms tend to get worse over time. Sufferers often cough up sputum and eventually there is damage to the tissues of the lung. The symptoms usually point to chronic obstructive pulmonary disease, but lung function tests are needed for diagnosis. Chronic obstructive pulmonary disease is also known as chronic obstructive lung disease (COLD), chronic obstructive airway disease (COAD), and chronic airflow limitation (CAL).
 

COPD Treatments

Chronic obstructive pulmonary disease treatments include quitting smoking, vaccines and drug therapies. Smoking is not the sole cause of obstructive pulmonary disease. Sometimes it is due occupational hazards where a person is inhaling harmful dust on a frequent basis. In these cases they can work to control and limit the amount of dust they inhale. Traditional chronic obstructive pulmonary disease treatments include several medications that help relax the airway muscles to improve breathing, things like bronchodilators and anticholinergics. Corticosteroids are sometimes used to reduce inflammation of the airways. Some patients require additional oxygen. In extreme cases surgery is performed to remove damaged sections of the lungs as treatment for chronic pulmonary disease.

Have multiple conditions? Click here

Showing 1-100 of 695
There are 695 Chronic Obstructive Pulmonary Disease Clinical Trials
Name City State Zip
Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial Birmingham AL 35216
Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial Birmingham AL 35216
Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial Port Orange FL 32129
Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial DeLand FL 32720
Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial DeLand FL 32720
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Montgomery AL
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Mobile AL
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects Jasper AL 35501
Effects of Tiotropium on Breathing Capacity and Exercise Limitation in Early Stages of Chronic Obstructive Pulmonary Disease Jasper AL
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Florence AL
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects Birmingham AL 35216
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects Birmingham AL 25233
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects Birmingham AL 35235
Simvastatin Therapy for Moderate and Severe COPD Birmingham AL 35233
Effects of Tiotropium on Breathing Capacity and Exercise Limitation in Early Stages of Chronic Obstructive Pulmonary Disease Birmingham AL
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Birmingham AL
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Birmingham AL
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Birmingham AL
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Birmingham AL
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Birmingham AL
IVR-Enhanced Care Transition Support for Complex Patients Birmingham AL 35294
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Athens AL
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Anchorage AK
Safety Study of CTX-100 Inhalation Solution (Formerly ETX-100) Tucson AZ 85712
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Tucson AZ
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Tucson AZ
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema Phoenix AZ 85006
A Pilot Study to Evaluate the ROX Anastomotic Coupler System in Patients With Chronic Obstructive Pulmonary Disease Phoenix AZ 85006
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Phoenix AZ
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Phoenix AZ
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Phoenix AZ
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Mesa AZ
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Mesa AZ
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Mesa AZ
A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Glendale AZ 85304
A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Glendale AZ 85304
A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Glendale AZ 85304
Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study Glendale AZ 85304
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Chandler AZ
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease AZ
Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease(COPD): Aim 1 Little Rock AR 72205
Essential Amino Acid Intake to Optimize Protein Anabolism in Elderly Chronic Obstructive Pulmonary Disorder (COPD) Patients Little Rock AR 72205
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Wildomar CA
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Walnut Creek CA
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Victorville CA
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Tustin CA
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema Torrance CA 90502
Simvastatin Therapy for Moderate and Severe COPD Torrance CA 90502
Effects of Tiotropium on Breathing Capacity and Exercise Limitation in Early Stages of Chronic Obstructive Pulmonary Disease Torrance CA
Symbicort in Airway Predominant Chronic Obstructive Pulmonary Disease (COPD) Torrance CA 90502
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Santa Barbara CA
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease San Jose CA
Prevalence and Pathogenesis of Lung Disease in a Large HIV Cohort-coordinating Center San Francisco CA 94143
Simvastatin Therapy for Moderate and Severe COPD San Francisco CA 94143
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects San Diego CA 92120
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease San Diego CA
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease San Diego CA
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease San Diego CA
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects Sacremento CA 95823
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects Sacramento CA 95825
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects Roseville CA 95661
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects Riverside CA 92506
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Redlands CA
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Rancho Cucamonga CA
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Poway CA
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Paramount CA
Investigating the Impact of Mode of Administration on Item Response Palo Alto CA 94301
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Palm Springs CA
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Orange CA
Prevalence and Pathogenesis of Lung Disease in a Large HIV Cohort-coordinating Center Los Angeles CA 90095
A Pilot Study to Evaluate the ROX Anastomotic Coupler System in Patients With Chronic Obstructive Pulmonary Disease Los Angeles CA 90024
Simvastatin Therapy for Moderate and Severe COPD Los Angeles CA 90073
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Los Angeles CA
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Los Angeles CA
Effect of Supplemental Vitamin D on Skeletal Muscle Function in Chronic Obstructive Pulmonary Disease (COPD) Patients Long Beach CA 90822
VISN 23 Chronic Obstructive Pulmonary Disease (COPD) Case Management Using Home Telehealth Equipment Long Beach CA 90822
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Lomita CA
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Lincoln CA
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Lancaster CA
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects Fullerton CA 92835
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Fullerton CA
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Fountain Valley CA
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Encinitas CA
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease Anaheim CA 92807
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects Anaheim CA 92801
A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Anaheim CA 92807
A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Anaheim CA 92807
A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Anaheim CA 92807
Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Anaheim CA 92807
Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study Anaheim CA 92807
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Wheat Ridge CO
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Wheat Ridge CO
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Fort Collins CO
Exploratory Study of Xolair in Chronic Obstructive Pulmonary Disease in Patients With Elevated IgE Levels Denver CO 80206
A Study to Evaluate Biomarkers in Chronic Obstructive Pulmonary Disease Denver CO
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects Denver CO 80206
Simvastatin Therapy for Moderate and Severe COPD Denver CO 80206
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Denver CO
Symbicort in Airway Predominant Chronic Obstructive Pulmonary Disease (COPD) Denver CO 80206
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Colorado Springs CO

Showing 1-100 of 695
Alabama - Alaska - Arizona - Arkansas - California - Colorado - Connecticut - Delaware - Washington DC - Florida - Georgia - Hawaii - Idaho - Illinois - Indiana - Iowa - Kansas - Kentucky - Louisiana - Maine - Maryland - Massachusetts - Michigan - Minnesota - Mississippi - Missouri - Montana - Nebraska - Nevada - New Hampshire - New Jersey - New Mexico - New York - North Carolina - North Dakota - Ohio - Oklahoma - Oregon - Pennsylvania - Rhode Island - South Carolina - South Dakota - Tennessee - Texas - Utah - Vermont - Virginia - Washington - West Virginia - Wisconsin - Wyoming
For Sponsors: Promote Your Study | For Research Sites: Promote Your Site

Copyright 2012 Clinical Trials Institute, LLC | All Rights Reserved
Login
Forgot password?
Enter your email and we will resend your password
Register